Atrial Fibrillation Surgery Market is projected to reach to reach USD 1.98 billi
Posted by rohan on January 12th, 2018
The Global Atrial Fibrillation Surgery Market was worth USD 1.02 billion in 2016, and is expected to grow at a CAGR of 14%, to reach USD 1.98 billion by 2021. Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, shortness of breath and heart palpitations.
View full report @ https://www.marketdataforecast.com/market-reports/atrial-fibrillation-surgery-market-4066/
Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.
Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.
Get free sample report @ https://www.marketdataforecast.com/market-reports/atrial-fibrillation-surgery-market-4066/request-sample
The Atrial Fibrillation Surgery Market is categorized based on the surgical procedure, product and region. Based on surgical procedure, the market is categorized into Catheter Ablation procedure and Surgical Ablation or Maze procedure. Based on product, the market is categorized into Catheter Ablation and Surgical Ablation. Catheter ablation surgical devices are expected to be the largest segment and are also expected be the fastest growing segment due to its high acceptance in surgical procedures.
Based on geography, the market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America leads the Atrial Fibrillation Surgery market due to availability of highly advanced healthcare infrastructure and adoption of highly advanced technologies. Asia Pacific is expected to be the fastest growing segment due to the large number of geriatric population who has a high risk of heart diseases.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/atrial-fibrillation-surgery-market-4066/inquire
Some of the major players in this region are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.
Scope of the report:
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author